Advertisement

Topics

Wedbush Securities Welcomes Eric Tansky as a Managing Director in the Healthcare Investment Banking Group

20:00 EDT 9 Aug 2015 | Globe Newswire

SAN FRANCISCO, CALIF., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Wedbush Securities, one of the nation's leading diversified financial services firms, is pleased to welcome Eric Tansky as a Managing Director in the Healthcare Investment Banking Group based in New York. Eric joins Wedbush from Jefferies Healthcare Investment Banking and will continue to focus on the Medical Technology sector. Over the past 10 years, Eric has completed 45 transactions representing over $62 billion in transaction value. Eric is a graduate of the United States Naval Academy, has an MBA from Columbia University, and spent several years as an OR-focused Orthopedic Consultant.

"As former colleagues at Merrill Lynch, I have known Eric for nearly a decade and am excited to team up with him again," states Scott T. Smith, Director of Healthcare Investment Banking at Wedbush. "Eric will bolster our industry coverage, particularly in medical technology, while adding to our strategic advisory capabilities and our equity origination platform."
 
Eric's hire further solidifies the firm's efforts in continuing to expand its capabilities and magnify its reach. "Our senior Healthcare Investment Banking team, including Eric, Kelly Lisbakken and Adam Levy, along with Ben Davey as Head of the Wedbush Equity Capital Markets group, forms the core of the Wedbush PacGrow Healthcare franchise. We continue to focus on advising and funding the most innovative companies in the industry, just as we have for the past three decades, and we will continue to pursue opportunities to better serve our clients by adding capabilities as appropriate," adds Scott.
 
The Wedbush Capital Markets group offers a wide range of products and services to corporate and institutional clients, which include equity, equity-linked and leverage financing, strategic advisory services, equity research, and market making and clearing services. The Wedbush Investment Banking Group, a division of Capital Markets, is composed of senior, industry-focused professionals who have extensive transactional backgrounds, long-standing industry relationships, and are dedicated to playing an active role in every transaction. The group evaluates and executes complex transactions that create long-term shareholder value.
 
About Wedbush Securities

Since our founding in 1955, Wedbush has been a leader in the financial industry providing our clients with a wide range of services; including retail and institutional sales, clearing services, equity research, corporate and municipal finance, equity market making, fixed income trading, and wealth management. Headquartered in Los Angeles, with over 100 registered offices, the firm focuses on relentless service, client financial safety, continuity, and advanced technology. Wedbush Securities is the largest subsidiary of holding company WEDBUSH, Inc., which also includes affiliated firms Wedbush Asset ManagementWedbush Capital PartnersWedbush Opportunity Partners, and Lime Brokerage LLC

Follow us on Twitter @Wedbush.

CONTACT: Teny Josephbek
         213-688-8057
         publicrelations@wedbush.com
NEXT ARTICLE

More From BioPortfolio on "Wedbush Securities Welcomes Eric Tansky as a Managing Director in the Healthcare Investment Banking Group"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...